Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Michonneau

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Bone Marrow Transplantation|June 2, 2022
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantationAurélien Sutra Del Galy, Adrien Rousseau, Antoine Capes, et al.
Cell Host & Microbe|July 18, 2023
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapsesNicolas Vallet, Maud Salmona, Jeanne Malet-Villemagne, et al.
British Journal of Haematology|April 12, 2021
Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre studyThomas Longval, Jacques-Emmanuel Galimard, Anne-Claire Leprêtre, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2025
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosisSara Villar, Emmanuel Curis, Marie-Hélène Schlageter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2019
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell TransplantationSimona Pagliuca, Côme Bommier, David Michonneau, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantationAudrey Moatti, Anais Debesset, Caroline Pilon, et al.
The Journal of Clinical Investigation|August 29, 2024
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analysesJennifer Bordenave, Dorota Gajda, David Michonneau, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Bone Marrow Transplantation|June 2, 2022
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantationAurélien Sutra Del Galy, Adrien Rousseau, Antoine Capes, et al.
Cell Host & Microbe|July 18, 2023
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapsesNicolas Vallet, Maud Salmona, Jeanne Malet-Villemagne, et al.
British Journal of Haematology|April 12, 2021
Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre studyThomas Longval, Jacques-Emmanuel Galimard, Anne-Claire Leprêtre, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2025
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosisSara Villar, Emmanuel Curis, Marie-Hélène Schlageter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2019
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell TransplantationSimona Pagliuca, Côme Bommier, David Michonneau, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantationAudrey Moatti, Anais Debesset, Caroline Pilon, et al.
The Journal of Clinical Investigation|August 29, 2024
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analysesJennifer Bordenave, Dorota Gajda, David Michonneau, et al.
Pageof 11